× Home About FPD Contact Us Media Courses Staff & Student Links

Link with us.

  Facebook   Instagram   LinkedIn   Youtube   Twitter

Clinical Management of Prostate Cancer - Contact Tuition

Interests: Management / Clinical Management / Prostate Cancer


Introduction

Prostate cancer is one of the most common cancers affecting the male population globally. It is rated the second leading cause of cancer death among males in the USA, and the most commonly diagnosed non-cutaneous malignancy. In Southern African men, prostate cancer has an incidence of 40.5 per 100 000 of the population per year, and a mortality rate of 22.5 per 100 000 per year. In South Africa, prostate screening is recommended across all men from age of 45 years onwards in the absence of identifiable risk factors (South African Prostate Cancer Foundation, 2013 Guidelines). The risk of getting prostate cancer increases after 50 years of age, with the annual incidence being the highest in men older than 70 years of age. Men with a family history of prostate cancer have an increased risk to develop the disease.

Dr Stan Moloabi, Executive Healthcare Manager at the Government Employees Medical Scheme (GEMS) believes that more has to be done to educate South African men about the disease – especially since if the disease is picked up early, it can be treated. “ Many South African men, as with men around the world, know relatively little about prostate and testicular cancers,” he says.

Treatment of the disease has improved over the years, and the sooner it is detected the higher the patient’s chances of survival. Prostate cancer occurs in a man’s prostate — a small walnut-shaped gland that forms part of the male reproductive system. Prostate cancer occurs when abnormal cells grow in the prostate gland.

Men who are over the age of 40 should visit their doctor for tests for prostate cancer once every two years. Men who are over the age of 50 should be screened once a year, he advises.

Enquire

Who Should Enrol

All Healthcare Professionals that are involved in Primary Health care who acquire knowledge and skills on the clinical management of Prostate Cancer.

Course Design

Distance education through a comprehensive self-study guide developed by experts in the field supported by a 1- day interactive contact session.

Assessment

Participants need to achieve a score of 70% on the assessment questionnaire in order to pass this aspect of the course.

Accreditation

Accredited according to the HPCSA’s Medical and Dental Board guidelines for Healthcare Professionals for 8 CEU’s on Level 2.

Course Content

  • Incidence
  • Etiology
  • Clinical presentation
  • Diagnostic approach
  • Indications for prostate biopsy
  • Histology

Fees


R 0.00 This course is fully sponsored through an educational grant from AstraZeneca.

Date Venue
8 October 2016 Johannesburg

Contact Details

Danielle Daniels Williamson

Tel: 012 816 9000 / 9257
Fax: 086 558 9535
E-mail: danielled@foundation.co.za

Lorez Flan

Tel: 012 816 90 00 / 9257
Fax: 086 558 9535
E-mail: lorezf@foundation.co.za

Enquire

Address: PO Box 75324, Lynnwood Ridge, 0040
Website: www.foundation.co.za